About Selkirk Pharma
Selkirk Pharma is a private company based in Spokane, Washington. It has reported $82,052,894 raised in five offerings on Form D since March 2018. Its chief executive is Patrick Haffey.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 25, 2023 | Sep 13, 2023 | $24,102,603of $25.0M target | 114 | $211K | EquityRule 506(b) | Form D ↗ |
| Dec 15, 2021 | Dec 30, 2021 | $35,000,005fully sold | 137 | $255K | EquityRule 506(b) | Form D ↗ |
| Aug 31, 2020 | Sep 15, 2020 | $12,174,000of $15.0M target | 79 | $154K | EquityRule 506(b) | Form D ↗ |
| Feb 7, 2020 | Feb 25, 2020 | $9,051,286of $18.0M target | 65 | $139K | EquityRule 506(b) | Form D ↗ |
| Feb 16, 2018 | Mar 2, 2018 | $1,725,000of $5.0M target | 19 | $90,789 | Equity, DebtRule 506(b) | Form D ↗ |
| Total, five offerings | $82,052,894 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Selkirk Pharma's Form D filed Sep 13, 2023.
PH
Patrick Haffey
President and CEO, director
JH
Joe Herzog
Executive officer and director
MC
Marshall Crew
Director
TT
Tom Tobin
Director
RR
Rod Raabe
Director